sandostatin 100 mikrogram/ml injektionsvæske, opløsning
novartis healthcare a/s - octreotid - injektionsvæske, opløsning - 100 mikrogram/ml
sandostatin lar 20 mg pulver og solvens til injektionsvæske, suspension
novartis healthcare a/s - octreotidacetat - pulver og solvens til injektionsvæske, suspension - 20 mg
sandostatin lar 30 mg pulver og solvens til injektionsvæske, suspension
novartis healthcare a/s - octreotidacetat - pulver og solvens til injektionsvæske, suspension - 30 mg
octreoanne 20 mg pulver og solvens til depotinjektionsvæske, suspension
teva b.v. - octreotidacetat - pulver og solvens til depotinjektionsvæske, suspension - 20 mg
octreoanne 30 mg pulver og solvens til depotinjektionsvæske, suspension
teva b.v. - octreotidacetat - pulver og solvens til depotinjektionsvæske, suspension - 30 mg
locametz
novartis europharm limited - gozetotide - radionuklidbilleddannelse - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
octreotid sun 0,1 mg/1 ml injektionsvæske, opløsning
orifarm a/s - octreotidacetat - injektionsvæske, opløsning - 0,1 mg/1 ml
fultium 68,5 mikrogram/ml orale dråber, opløsning
stada arzneimittel ag - cholecalciferol - orale dråber, opløsning - 68,5 mikrogram/ml
fultium 625 mikrogram/ml oral opløsning
stada arzneimittel ag - cholecalciferol - oral opløsning - 625 mikrogram/ml
litarex 6 mmol li+ depottabletter
teva b.v. - lithiumcitrat - depottabletter - 6 mmol li+